These results suggest that in cerebral ischemia model cells, the AMPK–CRBN interaction is weakened and phosphorylation of AMPK is enhanced, but thalidomide treatment restores the AMPK–CRBN interaction and suppresses phosphorylation of AMPK. The gene discussed is CRBN; the disease is Cerebral ischemia.